In our study, with some modifications to the Cre‐lox system, we created a new mouse model of skull base meningioma using Nf2 gene inactivation and the combined loss of P15Ink4b, P16Ink4a, and P19Arf. This evidence concerns the gene NF2 and skull base meningioma.